Terms: = Endocrine gland cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12
3253 results:
1. Timing and Ideal Patient for an Appropriate Search for Somatic
Matrone A; Prete A; Gambale C; Elisei R
JCO Precis Oncol; 2024 May; 8():e2400017. PubMed ID: 38709990
[TBL] [Abstract] [Full Text] [Related]
2. Spontaneous and Treatment-Related Changes of Serum Calcitonin in Medullary Thyroid cancer: Long-Term Experience in a Patient With Multiple endocrine Neoplasia Type 2B.
Réti Z; Tabák ÁG; Garami M; Kalina I; Kiss G; Sápi Z; Tóth M; Tőke J
JCO Precis Oncol; 2024 May; 8():e2300675. PubMed ID: 38709988
[TBL] [Abstract] [Full Text] [Related]
3. Loss of tumor suppressor TMEM127 drives ret-mediated transformation through disrupted membrane dynamics.
Walker TJ; Reyes-Alvarez E; Hyndman BD; Sugiyama MG; Oliveira LCB; Rekab AN; Crupi MJF; Cabral-Dias R; Guo Q; Dahia PLM; Richardson DS; Antonescu CN; Mulligan LM
Elife; 2024 Apr; 12():. PubMed ID: 38687678
[TBL] [Abstract] [Full Text] [Related]
4. [Multiple endocrine neoplasia and very early onset inflammatory bowel disease. An unexpected association].
Rossi SI; Baleani S; Prado X; Pascual C; Tennina C; Malagrino P; Vieites A; Parra A; Cazalla M; Castano JT; Lapunzina P
Medicina (B Aires); 2024; 84(2):347-350. PubMed ID: 38683522
[TBL] [Abstract] [Full Text] [Related]
5. Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options.
Jara MA
Crit Rev Oncog; 2024; 29(3):83-90. PubMed ID: 38683155
[TBL] [Abstract] [Full Text] [Related]
6. Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center.
Neocleous V; Fanis P; Toumba M; Skordis N; Phylactou LA
Orphanet J Rare Dis; 2024 Apr; 19(1):167. PubMed ID: 38637882
[TBL] [Abstract] [Full Text] [Related]
7. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
8. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
9. BRAF and ret polymorphism association with thyroid cancer risk, a preliminary study from Khyber Pakhtunkhwa population.
Batool M; Khan NU; Khan H; Almutairi MH; Ali I; Adams BD
Mol Biol Rep; 2024 Apr; 51(1):502. PubMed ID: 38598020
[TBL] [Abstract] [Full Text] [Related]
10. Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and ret Gene Rearrangement.
Xie M; Xu ZX; Dai M; Zhu YY
J Coll Physicians Surg Pak; 2024 Apr; 34(4):445-450. PubMed ID: 38576288
[TBL] [Abstract] [Full Text] [Related]
11. Advances in targeted therapy and biomarker research in thyroid cancer.
Guo M; Sun Y; Wei Y; Xu J; Zhang C
Front Endocrinol (Lausanne); 2024; 15():1372553. PubMed ID: 38501105
[TBL] [Abstract] [Full Text] [Related]
12. Accelerated men2a in homozygous ret carriers in the context of consanguinity.
Machens A; Dralle H
Eur J Endocrinol; 2024 Mar; 190(3):K43-K46. PubMed ID: 38465999
[TBL] [Abstract] [Full Text] [Related]
13. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
14. Molecular classification and tumor microenvironment characteristics in pheochromocytomas.
Qin S; Xu Y; Yu S; Han W; Fan S; Ai W; Zhang K; Wang Y; Zhou X; Shen Q; Gong K; Sun L; Zhang Z
Elife; 2024 Feb; 12():. PubMed ID: 38407266
[TBL] [Abstract] [Full Text] [Related]
15. The role of prophylactic parathyroidectomy during thyroidectomy for MTC in patients with men2a syndrome.
Kavazis C; Romanidis K; Pitiakoudis M; Kesisoglou I; Laskou S; Sapalidis K
Folia Med (Plovdiv); 2023 Oct; 65(5):720-727. PubMed ID: 38351753
[TBL] [Abstract] [Full Text] [Related]
16. ret kinase inhibitors for the treatment of ret-altered thyroid cancers: Current knowledge and future directions.
Hamidi S; Hu MI
Ann Endocrinol (Paris); 2024 Apr; 85(2):118-126. PubMed ID: 38342224
[TBL] [Abstract] [Full Text] [Related]
17. The Pathogenic ret Val804Met Variant in Acromegaly: A New Clinical Phenotype?
Chiloiro S; Capoluongo ED; Costanza F; Minucci A; Giampietro A; Infante A; Milardi D; Ricciardi Tenore C; De Bonis M; Gaudino S; Rindi G; Olivi A; De Marinis L; Pontecorvi A; Doglietto F; Bianchi A
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339173
[TBL] [Abstract] [Full Text] [Related]
18. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
19. Thyroid cancer: A Review.
Boucai L; Zafereo M; Cabanillas ME
JAMA; 2024 Feb; 331(5):425-435. PubMed ID: 38319329
[TBL] [Abstract] [Full Text] [Related]
20. [Intestinal ganglioneuromatosis as an early extra-endocrine manifestation of type 2B multiple endocrine neoplasia].
Averianova JV; Kalinchenko NY; Brovin DN; Petryaykina EE; Tiulpakov AN
Probl Endokrinol (Mosk); 2023 Jun; 69(6):109-112. PubMed ID: 38312000
[TBL] [Abstract] [Full Text] [Related]
[Next]